Corvidia: Novo snaps up cardio-renal group Corvidia
The moves gives the Danish drugmaker access to Corvidia's lead candidate ziltivekimab
Read full article »
Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.
Read more